MSI tumors develop unique immunological hubs within three key compartments: (1) tumor stroma, (2) myeloid cell-enriched regions (macrophages, dendritic cells, granulocytes), and (3) effector T cell zones expressing CXCR3 ligands at the tumor-lumen interface [71,72]. Here, CXCR3 is linked to neoplasm.